Microbiome Signature Linked to the Development and Management of Intestinal Acute Graft-versus-Host Disease in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation
Study shows microbiome diversity affects graft-versus-host disease in pediatric patients, suggesting new interventions.
Key Points
Patients developing graft-versus-host disease showed reduced gut microbiota diversity, particularly by day 14 post-transplant.
Increased pro-inflammatory bacteria were found in patients with graft-versus-host disease, while protective bacteria were more common in non-GVHD patients.
Machine learning techniques identified key microbial features that could predict outcomes for pediatric stem cell transplant patients.
Strategies aimed at preserving gut microbiota diversity could enhance transplantation success and mitigate the effects of graft-versus-host disease.